New directions in pharmacological treatment of acromegaly
about
sameAs
Somatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegalySomatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegalyKIT protein expression and mutational status of KIT gene in pituitary adenomas.Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure.Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly
P2860
New directions in pharmacological treatment of acromegaly
description
im Januar 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 2009
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2008
@uk
name
New directions in pharmacological treatment of acromegaly
@en
New directions in pharmacological treatment of acromegaly
@nl
type
label
New directions in pharmacological treatment of acromegaly
@en
New directions in pharmacological treatment of acromegaly
@nl
prefLabel
New directions in pharmacological treatment of acromegaly
@en
New directions in pharmacological treatment of acromegaly
@nl
P2860
P1476
New directions in pharmacological treatment of acromegaly
@en
P2093
Jens Bollerslev
Stine L Fougner
P2860
P356
10.1517/13543780802554357
P407
P50
P577
2009-01-01T00:00:00Z